Hannah Coleman

765 total citations
29 papers, 548 citations indexed

About

Hannah Coleman is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Hannah Coleman has authored 29 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 11 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Hannah Coleman's work include Cervical Cancer and HPV Research (15 papers), Immunotherapy and Immune Responses (11 papers) and Reproductive tract infections research (4 papers). Hannah Coleman is often cited by papers focused on Cervical Cancer and HPV Research (15 papers), Immunotherapy and Immune Responses (11 papers) and Reproductive tract infections research (4 papers). Hannah Coleman collaborates with scholars based in United States, United Kingdom and China. Hannah Coleman's co-authors include Mayumi Nakagawa, William W. Greenfield, Kathryn M. Thrailkill, John L. Fowlkes, R. Clay Bunn, Gael Cockrell, Dayle A. Daines, Horace J. Spencer, Arnold L. Smith and Pippa Simpson and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Hannah Coleman

27 papers receiving 538 citations

Peers

Countries citing papers authored by Hannah Coleman

Since Specialization

Citations

This map shows the geographic impact of Hannah Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Coleman more than expected).

Fields of papers citing papers by Hannah Coleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Coleman. The network helps show where Hannah Coleman may publish in the future.

Co-authorship network of co-authors of Hannah Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Coleman. A scholar is included among the top collaborators of Hannah Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Coleman. Hannah Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Harnessing Advanced Machine Learning Techniques for Microscopic Vessel Segmentation in Pulmonary Fibrosis Using Novel Hierarchical Phase-Contrast Tomography Images 2024 ·Methods of Information in Medicine ·(unknown), (unknown), Shahab Aslani, Moucheng Xu, (unknown), Robert Chapman, Hannah Coleman, Christopher Werlein, Claire Walsh, Peter Lee, Paul Tafforeau, Joseph Jacob	0
2	Physics-informed deep generative learning for quantitative assessment of the retina 2024 ·Nature Communications ·Emmeline Brown, (unknown), Natalie Holroyd, Paul W. Sweeney, (unknown), Hannah Coleman, Claire Walsh, Athina E. Markaki, Rebecca J. Shipley, Ranjan Rajendram, Simon Walker‐Samuel	9
3	Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus Candida adjuvant alone in treating cervical intraepithelial neoplasia 2/3. 2024 ·Journal of Clinical Oncology ·Mayumi Nakagawa, Teresa Evans, (unknown), Hannah Coleman, (unknown), (unknown), Yong‐Chen Lu, Intawat Nookaew, (unknown), (unknown), Takeo Shibata, David W. Ussery, William W. Greenfield	1
4	A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). 2023 ·Journal of Clinical Oncology ·Mayumi Nakagawa, Teresa Evans, Hannah Coleman, (unknown), (unknown), (unknown), (unknown), (unknown), Benjamin J. Lieblong, Yong‐Chen Lu, Intawat Nookaew, Yang Ou, Charles M. Quick, David W. Ussery, Michael S. Robeson, Sumit K. Shah, Takeo Shibata, Horace J. Spencer, H. Williams, William W. Greenfield	1
5	Evaluation of DNA extraction protocols from liquid-based cytology specimens for studying cervical microbiota 2021 ·PLoS ONE ·Takeo Shibata, Mayumi Nakagawa, Hannah Coleman, Sarah M. Owens, William W. Greenfield, Toshiyuki Sasagawa, Michael S. Robeson	10
6	Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed 2021 ·Frontiers in Immunology ·Takeo Shibata, Sumit K. Shah, Teresa Evans, Hannah Coleman, Benjamin J. Lieblong, Horace J. Spencer, Charles M. Quick, Toshiyuki Sasagawa, Owen Stephens, Erich A. Peterson, Donald J. Johann, Yong‐Chen Lu, Mayumi Nakagawa	8
7	Predicting dying from lung cancer: Urine metabolites predict the last weeks and days of life. 2021 ·Journal of Clinical Oncology ·(unknown), Elinor Chapman, J. Baker, Hannah Coleman, Brendan P. Norman, David M. Hughes, Andrew Davison, Stephen Mason, Mark T. Boyd, John Ellershaw, Chris Probert	1
8	An assessment of Oxford Nanopore sequencing for human gut metagenome profiling: A pilot study of head and neck cancer patients 2019 ·Journal of Microbiological Methods ·Thidathip Wongsurawat, Mayumi Nakagawa, Omar Atiq, Hannah Coleman, Piroon Jenjaroenpun, (unknown), (unknown), (unknown), David W. Ussery, Intawat Nookaew	14
9	Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination 2016 ·Cancer Immunology Immunotherapy ·Hannah Coleman, William W. Greenfield, Shawna L. Stratton, (unknown), (unknown), A. Moerman, Horace J. Spencer, (unknown), Charles M. Quick, Laura F. Hutchins, Samuel G. Mackintosh, Richard J. Edmondson, Stephen W. Erickson, Mayumi Nakagawa	50
10	Medium-chain triglycerides and conjugated linoleic acids in beverage form increase satiety and reduce food intake in humans 2016 ·Nutrition Research ·Hannah Coleman, Paul C. Quinn, Miriam Clegg	20
11	Cross-Reactivity, Epitope Spreading, andDe NovoImmune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines 2015 ·Clinical and Vaccine Immunology ·Mayumi Nakagawa, William W. Greenfield, A. Moerman, Hannah Coleman	26
12	Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine 2013 ·Vaccine ·(unknown), Hannah Coleman, Uma M. Nagarajan, Horace J. Spencer, Mayumi Nakagawa	22
13	IL-12 secretion by Langerhans cells stimulated with Candida skin test reagent is mediated by dectin-1 in some healthy individuals 2013 ·Cytokine ·Mayumi Nakagawa, Hannah Coleman, (unknown), (unknown), James D. Sikes, Uma M. Nagarajan	15
14	Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus 2012 ·Journal of Visualized Experiments ·(unknown), William W. Greenfield, Hannah Coleman, (unknown), Mayumi Nakagawa	6
15	CD8 T-Cell Responses in Incident and Prevalent Human Papillomavirus Types 16 and 18 Infections 2012 ·ISRN Obstetrics and Gynecology ·Hannah Coleman, Anna‐Barbara Moscicki, Sepideh Farhat, Sushil Gupta, Xuelian Wang, Mayumi Nakagawa	5
16	CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend 2011 ·Cancer Immunology Immunotherapy ·Kevin H. Kim, William W. Greenfield, Martin J. Cannon, Hannah Coleman, Horace J. Spencer, Mayumi Nakagawa	34
17	A Favorable Clinical Trend Is Associated With CD8 T-Cell Immune Responses to the Human Papillomavirus Type 16 E6 Antigens in Women Being Studied for Abnormal Pap Smear Results 2010 ·Journal of Lower Genital Tract Disease ·Mayumi Nakagawa, Sushil Gupta, Hannah Coleman, (unknown), (unknown), William W. Greenfield	19
18	Severe deficiencies of IGF-I, IGF-II, IGFBP-3, ALS and paradoxically high-normal bone mass in a child with insulin-resistance syndrome (Rabson-Mendenhall type) 2007 ·Growth Hormone & IGF Research ·John L. Fowlkes, R. Clay Bunn, Hannah Coleman, Bryan D. Hall, (unknown), Kathryn M. Thrailkill	7
19	Runt-Related Transcription Factor 2 (RUNX2) and RUNX2-Related Osteogenic Genes Are Down-Regulated throughout Osteogenesis in Type 1 Diabetes Mellitus 2007 ·Endocrinology ·John L. Fowlkes, R. Clay Bunn, Lichu Liu, Elizabeth C. Wahl, Hannah Coleman, Gael Cockrell, Daniel S. Perrien, Charles K. Lumpkin, Kathryn M. Thrailkill	93
20	Haemophilus influenzae Rd KW20 has virulence properties 2003 ·Journal of Medical Microbiology ·Dayle A. Daines, Leah A. Cohn, Hannah Coleman, Kwang Sik Kim, Arnold L. Smith	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact